• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

库欣病患者长期缓解后的肠道微生物失调。与心脏代谢风险的关系。

Gut microbial dysbiosis in patients with Cushing's disease in long-term remission. Relationship with cardiometabolic risk.

机构信息

Endocrinology and Nutrition Department, Germans Trias i Pujol Hospital and Research Institute, Badalona, Spain.

School of Medicine, Universitat Internacional de Catalunya (UIC), Barcelona, Spain.

出版信息

Front Endocrinol (Lausanne). 2023 Jun 5;14:1074757. doi: 10.3389/fendo.2023.1074757. eCollection 2023.

DOI:10.3389/fendo.2023.1074757
PMID:37342265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10278540/
Abstract

BACKGROUND

Patients with Cushing's disease (CD) in remission maintain an increased cardiovascular risk. Impaired characteristics of gut microbiome (dysbiosis) have been associated with several cardiometabolic risk factors.

METHODS

Twenty-eight female non-diabetic patients with CD in remission with a mean ± SD) age of 51 ± 9 years, mean ( ± SD) BMI, 26 ± 4, median (IQR) duration of remission, 11(4) years and 24 gender-, age, BMI-matched controls were included. The V4 region of the bacterial 16S rDNA was PCR amplified and sequenced to analyse microbial alpha diversity (Chao 1 index, observed number of species, Shannon index) and beta diversity analysis through the Principal Coordinates Analysis (PCoA) of weighted and unweighted UniFrac distances. Inter-group difference in microbiome composition was analysed using MaAsLin2.

RESULTS

The Chao 1 index was lower in CD as compared with controls (Kruskal-Wallis test, q = 0.002), indicating lower microbial richness in the former. Beta diversity analysis showed that faecal samples from CS patients clustered together and separated from the controls (Adonis test, p<0.05). , a genus form of the Actinobacteria phylum was present in CD patients only, whereas , a genus from , was scarcely detectable/undetectable in CD patients as well as , a genus of the family of the phylum. In CS, the Chao 1 index was associated with fibrinogen levels and inversely correlated with both triglyceride concentrations and the HOMA-IR index (p<0.05).

CONCLUSIONS

Patients with CS in remission have gut microbial dysbiosis which may be one of the mechanisms whereby cardiometabolic dysfunctions persist after "cure".

摘要

背景

缓解期库欣病(CD)患者仍存在心血管风险增加。肠道微生物群(失调)特征受损与多种心血管代谢危险因素相关。

方法

纳入 28 名缓解期女性非糖尿病 CD 患者(平均年龄 ± SD 为 51 ± 9 岁,平均 BMI 为 26 ± 4,缓解期中位数(IQR)为 11(4)年)和 24 名性别、年龄、BMI 匹配的对照者。扩增和测序细菌 16S rDNA 的 V4 区,以分析微生物 α多样性(Chao1 指数、观察到的物种数、香农指数)和通过主坐标分析(PCoA)对加权和非加权 UniFrac 距离进行β多样性分析。使用 MaAsLin2 分析微生物组组成的组间差异。

结果

CD 组的 Chao1 指数低于对照组(Kruskal-Wallis 检验,q = 0.002),表明前者的微生物丰富度较低。β多样性分析显示,CS 患者的粪便样本聚类在一起,与对照组分离(Adonis 检验,p<0.05)。仅在 CD 患者中存在属于放线菌门的 属,而在 CD 患者中几乎检测不到/无法检测到属于 目、 科的 属,也检测不到属于 门的 科的 属。在 CS 中,Chao1 指数与纤维蛋白原水平相关,与甘油三酯浓度和 HOMA-IR 指数呈负相关(p<0.05)。

结论

缓解期 CS 患者存在肠道微生物失调,这可能是“治愈”后心血管代谢功能障碍持续存在的机制之一。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96f/10278540/e8c8949edfd3/fendo-14-1074757-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96f/10278540/aeab8187cd1b/fendo-14-1074757-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96f/10278540/4d0084bd8200/fendo-14-1074757-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96f/10278540/be5a557e5264/fendo-14-1074757-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96f/10278540/e8c8949edfd3/fendo-14-1074757-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96f/10278540/aeab8187cd1b/fendo-14-1074757-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96f/10278540/4d0084bd8200/fendo-14-1074757-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96f/10278540/be5a557e5264/fendo-14-1074757-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c96f/10278540/e8c8949edfd3/fendo-14-1074757-g004.jpg

相似文献

1
Gut microbial dysbiosis in patients with Cushing's disease in long-term remission. Relationship with cardiometabolic risk.库欣病患者长期缓解后的肠道微生物失调。与心脏代谢风险的关系。
Front Endocrinol (Lausanne). 2023 Jun 5;14:1074757. doi: 10.3389/fendo.2023.1074757. eCollection 2023.
2
Dysbiosis of gut microbiota and decreased propionic acid associated with metabolic abnormality in Cushing's syndrome.肠道微生物群落失调和丙酸减少与库欣综合征的代谢异常有关。
Front Endocrinol (Lausanne). 2023 Jan 23;13:1095438. doi: 10.3389/fendo.2022.1095438. eCollection 2022.
3
Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.中国炎症性肠病患者的粪便微生物失调。
World J Gastroenterol. 2018 Apr 7;24(13):1464-1477. doi: 10.3748/wjg.v24.i13.1464.
4
Characteristics of Faecal Microbiota in Paediatric Crohn's Disease and Their Dynamic Changes During Infliximab Therapy.儿童克罗恩病粪便微生物群特征及其在英夫利昔单抗治疗中的动态变化。
J Crohns Colitis. 2018 Feb 28;12(3):337-346. doi: 10.1093/ecco-jcc/jjx153.
5
The Specific Alteration of Gut Microbiota in Diabetic Kidney Diseases-A Systematic Review and Meta-Analysis.糖尿病肾病中肠道微生物组的特定改变——系统评价和荟萃分析。
Front Immunol. 2022 Jun 17;13:908219. doi: 10.3389/fimmu.2022.908219. eCollection 2022.
6
Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease.克罗恩病治疗过程中黏膜相关肠道微生物群的特征。
World J Gastroenterol. 2019 May 14;25(18):2204-2216. doi: 10.3748/wjg.v25.i18.2204.
7
Surviving ectopic Cushing's syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up.存活的异位库欣综合征:与库欣病相比,在长期随访中生活质量、心血管和代谢结局。
Eur J Endocrinol. 2018 Aug;179(2):109-116. doi: 10.1530/EJE-18-0212. Epub 2018 Jun 6.
8
Dysbiosis of gut microbiota in patients with esophageal cancer.食管癌患者肠道微生物失调。
Microb Pathog. 2021 Jan;150:104709. doi: 10.1016/j.micpath.2020.104709. Epub 2020 Dec 27.
9
Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission.不同病因库欣综合征患者在疾病活跃期和缓解后 1 年的代谢和心血管结局。
Clin Endocrinol (Oxf). 2011 Sep;75(3):354-60. doi: 10.1111/j.1365-2265.2011.04055.x.
10
Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.克罗恩病粪便宏基因组的调控:miRNAs 作为生物标志物的作用。
World J Gastroenterol. 2018 Dec 14;24(46):5223-5233. doi: 10.3748/wjg.v24.i46.5223.

引用本文的文献

1
Xianyu capsule ameliorates neuroinflammatory and glycerophospholipid metabolism in lithium-pilocarpine-induced acute epilepsy.闲鱼胶囊改善锂-匹罗卡品诱导的急性癫痫中的神经炎症和甘油磷脂代谢。
Front Nutr. 2025 Aug 13;12:1625533. doi: 10.3389/fnut.2025.1625533. eCollection 2025.
2
The gut microbiome in patients with Cushing's disease affects depression- and anxiety-like behavior in mice.库欣病患者的肠道微生物群会影响小鼠的抑郁和焦虑样行为。
Microbiome. 2024 Nov 1;12(1):225. doi: 10.1186/s40168-024-01939-1.
3
Altered Gut Microbiome Composition in Dogs with Hyperadrenocorticism: Key Bacterial Genera Analysis.

本文引用的文献

1
Dysbiosis of gut microbiota and decreased propionic acid associated with metabolic abnormality in Cushing's syndrome.肠道微生物群落失调和丙酸减少与库欣综合征的代谢异常有关。
Front Endocrinol (Lausanne). 2023 Jan 23;13:1095438. doi: 10.3389/fendo.2022.1095438. eCollection 2022.
2
Gastrointestinal Microbiome and Multiple Health Outcomes: Umbrella Review.胃肠道微生物组与多种健康结局:伞式综述。
Nutrients. 2022 Sep 9;14(18):3726. doi: 10.3390/nu14183726.
3
Cardiovascular complications of Cushings syndrome: Impact on morbidity and mortality.
患有肾上腺皮质功能亢进症的犬类肠道微生物群组成改变:关键细菌属分析
Animals (Basel). 2024 Oct 7;14(19):2883. doi: 10.3390/ani14192883.
库欣综合征的心血管并发症:对发病率和死亡率的影响。
J Neuroendocrinol. 2022 Aug;34(8):e13175. doi: 10.1111/jne.13175. Epub 2022 Jun 28.
4
How Diet and Physical Activity Modulate Gut Microbiota: Evidence, and Perspectives.饮食和身体活动如何调节肠道菌群:证据和观点。
Nutrients. 2022 Jun 14;14(12):2456. doi: 10.3390/nu14122456.
5
Microbiota medicine: towards clinical revolution.微生物组医学:走向临床革命。
J Transl Med. 2022 Mar 7;20(1):111. doi: 10.1186/s12967-022-03296-9.
6
Microbiota and Metabolite Profiling as Markers of Mood Disorders: A Cross-Sectional Study in Obese Patients.肠道菌群和代谢产物分析作为心境障碍的标志物:肥胖患者的横断面研究。
Nutrients. 2021 Dec 29;14(1):147. doi: 10.3390/nu14010147.
7
Multivariable association discovery in population-scale meta-omics studies.基于人群的宏基因组学研究中的多变量关联发现。
PLoS Comput Biol. 2021 Nov 16;17(11):e1009442. doi: 10.1371/journal.pcbi.1009442. eCollection 2021 Nov.
8
Auto-immunity and the gut microbiome in type 1 diabetes: Lessons from rodent and human studies.1 型糖尿病中的自身免疫和肠道微生物组:来自啮齿动物和人类研究的启示。
Best Pract Res Clin Endocrinol Metab. 2021 May;35(3):101544. doi: 10.1016/j.beem.2021.101544. Epub 2021 May 1.
9
Quality of life in Cushing's syndrome.库欣综合征患者的生活质量。
Best Pract Res Clin Endocrinol Metab. 2021 Jan;35(1):101505. doi: 10.1016/j.beem.2021.101505. Epub 2021 Feb 17.
10
Gut microbiota in human metabolic health and disease.人体肠道微生物群与代谢健康和疾病。
Nat Rev Microbiol. 2021 Jan;19(1):55-71. doi: 10.1038/s41579-020-0433-9. Epub 2020 Sep 4.